Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-06-29
DOI
10.3389/fncel.2016.00164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Strategies in Early and Advanced Parkinson Disease
- (2015) Christiana Ossig et al. NEUROLOGIC CLINICS
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor
- (2015) Curt A. Dvorak et al. ACS Medicinal Chemistry Letters
- Computer-Aided Discovery of Aromatic l-α-Amino Acids as Agonists of the Orphan G Protein-Coupled Receptor GPR139
- (2014) Vignir Isberg et al. Journal of Chemical Information and Modeling
- Clinical spectrum of levodopa-induced complications
- (2014) Camila Catherine Aquino et al. MOVEMENT DISORDERS
- Copy Number Variation Distribution in Six Monozygotic Twin Pairs Discordant for Schizophrenia
- (2014) Christina A. Castellani et al. Twin Research and Human Genetics
- Parkinson’s disease: animal models and dopaminergic cell vulnerability
- (2014) Javier Blesa et al. Frontiers in Neuroanatomy
- Dietary fat intake, pesticide use, and Parkinson's disease
- (2013) Freya Kamel et al. PARKINSONISM & RELATED DISORDERS
- Genome-Wide Association Study of Inattention and Hyperactivity–Impulsivity Measured as Quantitative Traits
- (2013) Jane L. Ebejer et al. Twin Research and Human Genetics
- A Guide to Neurotoxic Animal Models of Parkinson's Disease
- (2013) K. Tieu Cold Spring Harbor Perspectives in Medicine
- Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells
- (2012) Ju-Xian Song et al. NEUROSCIENCE LETTERS
- Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death
- (2012) Samantha Giordano et al. PLoS One
- Rotenone, Paraquat, and Parkinson’s Disease
- (2011) Caroline M. Tanner et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139
- (2011) Feng Shi et al. ACS Medicinal Chemistry Letters
- Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson’s disease
- (2008) Florian Nagel et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat
- (2008) W.-S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture
- (2007) Khaled Radad et al. TOXICOLOGY IN VITRO
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started